PlainPharmaWatch

CMS Open Payments · Program Year 2024

Otsuka Pharmaceutical Co., Ltd.

Otsuka Pharmaceutical Co., Ltd. reported $2,478,267.34 in payments to 193 physicians and teaching hospitals across 213 transactions.

See the rankings → How this is sourced
$2.5M
Total payments
213
Transactions
193
Recipients
−$228.3K
General Payments vs PY2023

Otsuka Pharmaceutical Co., Ltd. reported $2,478,267.34 in payments to 193 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #406 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $12.8K per recipient across 5 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Otsuka Pharmaceutical Co., Ltd. pairs top-quartile payment volume with a moderately concentrated payment pattern.

#406
of 1,925 companies
0.0%
of all US industry payments
0.2%
paid to its single top recipient
5
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Otsuka Pharmaceutical Co., Ltd.'s CMS-reported General Payments decreased by $228.3K (−39.0%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: OTSUKA PHARMACEUTICAL CO., LTD.PY2023: OTSUKA PHARMACEUTICAL CO., LTD.PY2024: Otsuka Pharmaceutical Co., Ltd.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$585.5KPY2024$357.1K
PY2023
$585,468.87
PY2024
$357,128.90

How Otsuka Pharmaceutical Co., Ltd. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Otsuka Pharmaceutical Co., Ltd.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$2,478,267 Top 21% higher than 79% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). This entry sits in this band. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Otsuka Pharmaceutical Co., Ltd.

Otsuka Pharmaceutical Co., Ltd. ranks #406 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $2,478,267.34 across 213 transactions to 193 physicians and teaching hospitals - $11.6K per transaction and $12.8K per recipient on average.

101 transactions worth $109.5K make "Travel and Lodging" the top general-payment category in the 5-category breakdown below, 4.4% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Otsuka Pharmaceutical Co., Ltd. made 5 types of general payments. "Travel and Lodging" is the largest category at $109.5K, 4.4% of the company's reported total.

How Otsuka Pharmaceutical Co., Ltd. divides its payments

How the reported total splits across payment categories

1. Travel and Lodging$109.5K2. Royalty or License$105.0K3. Compensation for Services…$87.4K4. Consulting Fee$52.6K5. Food and Beverage$2.6K
Payment Type Amount Transactions
Travel and Lodging $109.5K 101
Royalty or License $105.0K 2
Compensation for Services Other Than Consulting $87.4K 14
Consulting Fee $52.6K 26
Food and Beverage $2.6K 50

Recipient Concentration in General Payments

The five largest recipient relationships account for $248,988.21 (69.7%) of $357,128.90 in this company's General Payments records across 28 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Otsuka Pharmaceutical Co., Ltd.

The five named recipients with the highest reported General Payments from this company

Cleveland Clinic Hospital$85.0KGeorge Grossberg$82.1KMichael Thase$33.9KChristoph Correll$28.0KChildrens Hospital Corporati…$20.0K
  1. 1

    Cleveland Clinic Hospital

    $85,000.00 across 1 reported transactions

  2. 2

    George Grossberg

    $82,078.80 across 45 reported transactions

  3. 3

    Michael Thase

    $33,916.34 across 22 reported transactions

  4. 4

    Christoph Correll

    $27,993.07 across 37 reported transactions

  5. 5

    Childrens Hospital Corporation

    $20,000.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $11.6K. Average per recipient: $12.8K.

Total Amount

$2,478,267.34

Avg per Transaction

$11.6K

Avg per Recipient

$12.8K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Otsuka Pharmaceutical Co., Ltd. Share

0.0%

#406 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Otsuka Pharmaceutical Co., Ltd.

CoapTech, Inc.

$2.5M 41 recipients

Tolmar, Inc.

$2.5M 10,552 recipients

MED-EL Corporation

$2.5M 1,224 recipients

Centerline Biomedical Inc.

$2.5M 53 recipients

Synthes GmbH

$2.5M 2,666 recipients

AstraZeneca AB

$2.5M 46 recipients

Frequently Asked Questions

How much did Otsuka Pharmaceutical Co., Ltd. pay to physicians and hospitals in 2024? ▾
0.0% of all industry payments reported to CMS Open Payments for 2024 came from Otsuka Pharmaceutical Co., Ltd., totaling $2,478,267.34 across 213 transactions to physicians and hospitals.
How many physicians received payments from Otsuka Pharmaceutical Co., Ltd.? ▾
193 physicians and teaching hospitals received payments from Otsuka Pharmaceutical Co., Ltd. in 2024, averaging $12.8K per recipient.
What types of payments did Otsuka Pharmaceutical Co., Ltd. make? ▾
General payments from Otsuka Pharmaceutical Co., Ltd. span 5 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Travel and Lodging" at $109.5K, representing 4.4% of the company's reported total.
How does Otsuka Pharmaceutical Co., Ltd. rank among pharmaceutical companies? ▾
Otsuka Pharmaceutical Co., Ltd. ranks #406 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Otsuka Pharmaceutical Co., Ltd.? ▾
In 2024, Otsuka Pharmaceutical Co., Ltd. averaged $11.6K per transaction across 213 transactions to 193 recipients.
Where does the payment data for Otsuka Pharmaceutical Co., Ltd. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Otsuka Pharmaceutical Co., Ltd.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.